These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30512650)

  • 1. [Should we prescribe statins for primary prevention of cardiovascular risk? Rather yes].
    Béliard-Lasserre S
    Rev Prat; 2016 Mar; 66(3):332-334. PubMed ID: 30512650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Should we prescribe statins for primary prevention of cardiovascular risk? Rather no].
    Lecerf JM
    Rev Prat; 2016 Mar; 66(3):334-337. PubMed ID: 30512651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-Analysis.
    Teng M; Lin L; Zhao YJ; Khoo AL; Davis BR; Yong QW; Yeo TC; Lim BP
    Drugs Aging; 2015 Aug; 32(8):649-61. PubMed ID: 26245770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benefits and risks for primary prevention with statins in the elderly].
    Joseph JP; Afonso M; Berdaï D; Salles N; Bénard A; Gay B; Bonnet F
    Presse Med; 2015 Dec; 44(12 Pt 1):1219-25. PubMed ID: 26585744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins for the primary prevention of cardiovascular events in older adults: a review of the evidence.
    Ali R; Alexander KP
    Am J Geriatr Pharmacother; 2007 Mar; 5(1):52-63. PubMed ID: 17608248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease.
    Thanassoulis G; Williams K; Altobelli KK; Pencina MJ; Cannon CP; Sniderman AD
    Circulation; 2016 Apr; 133(16):1574-81. PubMed ID: 26945047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Statins in primary prevention of cardiovascular disease].
    Adham S; Miranda S; Doucet J; Lévesque H; Benhamou Y
    Rev Med Interne; 2018 Jan; 39(1):42-49. PubMed ID: 28866432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin therapy for primary prevention of cardiovascular disease.
    Taylor FC; Huffman M; Ebrahim S
    JAMA; 2013 Dec; 310(22):2451-2. PubMed ID: 24276813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statins in secondary prevention of cardiovascular risk].
    Caussy C; Charrière S; Moulin P
    Rev Prat; 2016 Mar; 66(3):322-326. PubMed ID: 30512646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are statins effective in high-risk primary prevention?
    Dentali F; Guasti L
    Arch Intern Med; 2010 Dec; 170(22):2042-3; author reply 2043-4. PubMed ID: 21149769
    [No Abstract]   [Full Text] [Related]  

  • 13. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
    Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
    J Am Coll Cardiol; 2008 Nov; 52(22):1769-81. PubMed ID: 19022156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials.
    Thavendiranathan P; Bagai A; Brookhart MA; Choudhry NK
    Arch Intern Med; 2006 Nov; 166(21):2307-13. PubMed ID: 17130382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and all-cause mortality in high-risk primary prevention: a second look at the results.
    Chodick G; Shalev V
    Arch Intern Med; 2010 Dec; 170(22):2041-2; author reply 2043-4. PubMed ID: 21149767
    [No Abstract]   [Full Text] [Related]  

  • 17. Women Versus Men: Is There Equal Benefit and Safety from Statins?
    Plakogiannis R; Arif SA
    Curr Atheroscler Rep; 2016 Feb; 18(2):6. PubMed ID: 26782824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of statin treatment based on cardiovascular outcomes in elderly patients: a standard meta-analysis and Bayesian network analysis.
    Zhai C; Hou K; Li R; Hu Y; Zhang J; Zhang Y; Wang L; Zhang R; Cong H
    J Int Med Res; 2020 Jun; 48(6):300060520926349. PubMed ID: 32529863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years: A Meta-analysis.
    Yourman LC; Cenzer IS; Boscardin WJ; Nguyen BT; Smith AK; Schonberg MA; Schoenborn NL; Widera EW; Orkaby A; Rodriguez A; Lee SJ
    JAMA Intern Med; 2021 Feb; 181(2):179-185. PubMed ID: 33196766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary prevention of cardiovascular diseases with statins in women].
    Alici G; Karpuz V; Karpuz H
    Turk Kardiyol Dern Ars; 2009 Jun; 37(4):273-80. PubMed ID: 19717964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.